274 related articles for article (PubMed ID: 27428881)
1. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.
Lee YJ; Chung D; Xiao K; Papadopoulos EB; Barker JN; Small TN; Giralt SA; Zheng J; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):387-92. PubMed ID: 23092814
[TBL] [Abstract][Full Text] [Related]
3. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
Qian C; Campidelli A; Wang Y; Cai H; Venard V; Jeulin H; Dalle JH; Pochon C; D'aveni M; Bruno B; Paillard C; Vigouroux S; Jubert C; Ceballos P; Marie-Cardine A; Galambrun C; Cholle C; Clerc Urmes I; Petitpain N; De Carvalho Bittencourt M; Decot V; Reppel L; Salmon A; Clement L; Bensoussan D
J Hematol Oncol; 2017 May; 10(1):102. PubMed ID: 28482908
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival.
Bruno B; Gooley T; Hackman RC; Davis C; Corey L; Boeckh M
Biol Blood Marrow Transplant; 2003 May; 9(5):341-52. PubMed ID: 12766884
[TBL] [Abstract][Full Text] [Related]
5. Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.
Ip W; Silva JMF; Gaspar H; Mitra A; Patel S; Rao K; Chiesa R; Amrolia P; Gilmour K; Ahsan G; Slatter M; Gennery AR; Wynn RF; Veys P; Qasim W
Cytotherapy; 2018 Jun; 20(6):830-838. PubMed ID: 29753677
[TBL] [Abstract][Full Text] [Related]
6. Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation.
Taniguchi K; Yoshihara S; Tamaki H; Fujimoto T; Ikegame K; Kaida K; Nakata J; Inoue T; Kato R; Fujioka T; Okada M; Soma T; Ogawa H
Ann Hematol; 2012 Aug; 91(8):1305-12. PubMed ID: 22476883
[TBL] [Abstract][Full Text] [Related]
7. Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.
Papanicolaou GA; Dvorak CC; Dadwal S; Maron G; Prasad VK; Giller R; Abdel-Azim H; Sadanand A; Casciano R; Chandak A; Huang S; Nichols G; Brundage T; Vainorius E; Mozaffari E; Hutcheson R
Transpl Infect Dis; 2020 Aug; 22(4):e13283. PubMed ID: 32267590
[TBL] [Abstract][Full Text] [Related]
8. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation.
Hoffman JA; Shah AJ; Ross LA; Kapoor N
Biol Blood Marrow Transplant; 2001; 7(7):388-94. PubMed ID: 11529489
[TBL] [Abstract][Full Text] [Related]
10. Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia.
Omar H; Yun Z; Lewensohn-Fuchs I; Pérez-Bercoff L; Orvell C; Engström L; Vuong GK; Ljungman P
Transpl Infect Dis; 2010 Oct; 12(5):465-9. PubMed ID: 20553439
[TBL] [Abstract][Full Text] [Related]
11. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation.
Schilham MW; Claas EC; van Zaane W; Heemskerk B; Vossen JM; Lankester AC; Toes RE; Echavarria M; Kroes AC; van Tol MJ
Clin Infect Dis; 2002 Sep; 35(5):526-32. PubMed ID: 12173125
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.
Lee YJ; Fang J; Zavras PD; Prockop SE; Boulad F; Tamari R; Perales MA; Papadopoulos EB; Jakubowski AA; Giralt SA; Papanicolaou GA
J Infect Dis; 2020 Sep; 222(7):1180-1187. PubMed ID: 32374872
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Adenovirus Infection in Hematopoietic Stem Cell Transplantation Recipients: Findings from the AdVance Study.
Sedláček P; Petterson T; Robin M; Sivaprakasam P; Vainorius E; Brundage T; Chandak A; Mozaffari E; Nichols G; Voigt S
Biol Blood Marrow Transplant; 2019 Apr; 25(4):810-818. PubMed ID: 30578939
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.
Watson T; MacDonald D; Song X; Bromwich K; Campos J; Sande J; DeBiasi RL
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1227-34. PubMed ID: 22281300
[TBL] [Abstract][Full Text] [Related]
15. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome.
Watcharananan SP; Kiertiburanakul S; Piyatuctsanawong W; Anurathapan U; Sungkanuparph S; Pakakasama S; Chantratita W; Hongeng S
Pediatr Transplant; 2010 Aug; 14(5):675-81. PubMed ID: 20412509
[TBL] [Abstract][Full Text] [Related]
18. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.
Lee YJ; Huang YT; Kim SJ; Maloy M; Tamari R; Giralt SA; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2016 Jan; 22(1):174-8. PubMed ID: 26318614
[TBL] [Abstract][Full Text] [Related]
20. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
